Scott Pelley spoke with Susan Desmond Hellman, the chancellor of UCSF and the head of the drug development company Genentech, on how the United States will create new jobs to fix the struggling economy.
The key here is that venture capital was available for new companies- there has been no new vc backing in years in biotech or the other industries that built our tech base.
The key here is that venture capital was available for new companies- there has been no new vc backing in years in biotech or the other industries that built our tech base.
multipleverses 3 months ago